Medicaid Fraud, COVID Vaccine Deaths, Eli Lilly PBM Moves, Health Care Economics

Send us Fan MailSend us a textKeywordshealthcare, Medicaid fraud, DEI, vaccine safety, Eli Lilly, ACA, healthcare policy, trust in medicine, social determinants of health, healthcare reformSummaryIn this episode, the hosts discuss various pressing issues in healthcare, including Medicaid fraud, the impact of fraud on legitimate healthcare needs, and the ongoing debate about healthcare as a human right. They also discuss the recent report by the FDA on children that may have died as a result of receiving the COVID vaccine, trust in vaccines, and Eli Lilly's move away from a traditional Pharmacy Benefit Manager. The conversation culminates in a discussion about the future of the ACA and necessary reforms in healthcare policy.TakeawaysMedicaid fraud is a significant issue with large-scale implications.Weaponizing empathy can hinder legitimate inquiries into healthcare fraud.The optimal amount of fraud in a system is not zero, as it may indicate necessary services are being provided.Healthcare is increasingly viewed through the lens of social determinants like housing and food security.Trust in vaccines is crucial, and transparency in data is necessary to maintain that trust.Eli Lilly's shift to direct-to-consumer models may reshape the pharmaceutical landscape.Direct-to-consumer healthcare models can increase access and reduce costs for patients.The ACA requires significant reforms to address rising healthcare costs and insurance company profits.Healthcare policy discussions must include physician voices to be effective.The debate over healthcare as a human right continues to evolve, with various perspectives on its implications. Sound bites"Medicaid is full of fraud.""Trust in medicine is eroding.""The ACA needs a major overhaul."Chapters00:00 Introduction to Healthcare Buzz00:51 Medicaid Fraud in Minnesota03:42 Weaponizing DEI in Healthcare07:12 The Complexity of Medicaid and Fraud09:57 Healthcare vs. Social Responsibility12:07 Empathy vs. Virtue Signaling in Healthcare15:58 FDA and Vaccine Concerns22:41 Trust in Vaccines and Public Health32:42 Eli Lilly's Shift in Pharmacy Strategy38:53 The Future of Patient Care and Market Dynamics42:13 Nutrition's Role in Health and Disease46:16 Economic Perspectives on Healthcare51:27 Proposals for Healthcare Reform57:21 The Debate on Insurance Models and Market Solutions🔗 Connect with the Hosts: • Dutch Rojas on X • Dr. Anthony DiGiorgio on X • Dr. Anish Koka on X • Dr. Dan Choi on X • Dr. Sanat Dixit on X🔗 Connect with the Hosts:• Dutch Rojas on X• Dr. Anthony DiGiorgio on X• Dr. Anish Koka on X• Dr. Dan Choi on X• Dr. Sanat Dixit on X